GlassScriptPhysician profile
Kayla Nicole Wright
NPI 1205448719
$1,964.36
in general payments reported to CMS, 2019-2025
15 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $516 · 2023: $446 · 2024: $459 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $625.77 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $518.76 | 2022-2025 | |
| Lilly USA, LLC | $285.93 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $114.87 | 2021-2025 | |
| Boston Scientific Corporation | $86.05 | 2025 | General - Pain Management |
| Takeda Pharmaceuticals U.S.A., INC. | $72.12 | 2021-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.10 | 2021-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.60 | 2021-2022 | |
| Axsome Therapeutics, INC. | $34.21 | 2025 | Symbravo |
| Idorsia Pharmaceuticals US INC | $30.63 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $29.40 | 2023 | Cologuard Collection Kit |
| Biotronik Nro, INC. | $19.93 | 2025 | |
| Ibsa Pharma INC. | $17.43 | 2024 | Licart, Tirosint, Flector |
| Glaxosmithkline, LLC. | $16.70 | 2024 | Arexvy, Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $13.86 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.